Reducing short-acting beta-agonist overprescribing in general practice: Evaluation of a quality improvement programme in East London

Key Points

• The research aims to evaluate a quality improvement programme designed to reduce the overprescribing of short-acting beta-agonists in general practice.
• Implemented a quality improvement programme in East London practices
• Provided individual coaching for effective use of electronic tools
• Utilized integrated prescribing alerts to monitor prescriptions
• Promoted a culture of collaborative practice for strategy implementation
• Notable reduction in short-acting beta-agonist overuse
• Potential decrease in hospital admissions due to lower overprescribing
• Faster implementation of improvement strategies in supportive practice environments